CVS HEALTH Corp — Director's Dealing 2021

Jan 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-01-19

Reporting Person: MERLO LARRY J (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-19	Common Stock	M	64350	$74.29	Acquired	586221.9407	Direct
2021-01-19	Common Stock	S	62893	$77.00	Disposed	523328.9407	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-19	Stock Option	$74.29	M	64350	Disposed	2021-04-01	Common Stock (64350)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	403808.084	Indirect
Common Stock (restricted)	40701	Direct
ESOP Common Stock	7304	Indirect
Stock Unit	684489.1285	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Phantom Stock Credits	$1.00		Common Stock (5151.9988)	5151.9988	Direct
Stock Option	$102.26	2022-04-01	Common Stock (273929)	273929	Direct
Stock Option	$104.82	2023-04-01	Common Stock (286787)	286787	Direct
Stock Option	$78.05	2024-04-03	Common Stock (338105)	338105	Direct
Stock Option	$62.21	2025-04-01	Common Stock (394091)	394091	Direct
Stock Option	$54.19	2029-04-01	Common Stock (545419)	545419	Direct
Stock Option	$58.34	2030-04-01	Common Stock (478711)	478711	Direct

Footnotes

F1: All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.

F2: Option became exercisable in four equal annual installments, commencing 4/1/2015.

F3: Each share credit is equivalent to one share; 1-for-1 conversion.

F4: Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.

F5: Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.

F6: Option became exercisable in four equal annual installments, commencing 4/1/2016.

F7: Option became exercisable in four equal annual installments, commencing 4/1/2017.

F8: Option became exercisable in four equal annual installments, commencing 4/3/2018.

F9: Option became exercisable in four equal annual installments, commencing 4/1/2019.

F10: Option became exercisable in four equal annual installments, commencing 4/1/2020.

F11: The number of shares subject to the option were calculated using a 30-day average price.

F12: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.